These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9190966)

  • 21. Transvaginal sonography of postmenopausal ovaries with pathologic correlation.
    Fleischer AC; McKee MS; Gordon AN; Page DL; Kepple DM; Worrell JA; Jones HW; Burnett LS; James AE
    J Ultrasound Med; 1990 Nov; 9(11):637-44. PubMed ID: 2258995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging.
    Weiner Z; Beck D; Shteiner M; Borovik R; Ben-Shachar M; Robinzon E; Brandes JM
    J Ultrasound Med; 1993 Jul; 12(7):387-93. PubMed ID: 8355333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
    Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
    Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
    Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
    Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
    Holbert TR
    Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
    Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR
    Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
    Lykins EL; Pavlik EL; Andrykowski MA
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian cancer screening.
    van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
    Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study to compare endometrial cytology and transvaginal ultrasonography for identification of endometrial malignancies.
    Tsuda H; Kawabata M; Yamamoto K; Inoue T; Umesaki N
    Gynecol Oncol; 1997 Jun; 65(3):383-6. PubMed ID: 9190961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
    Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
    Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional and color Doppler transvaginal sonography of pelvic masses: a comparison of relative histologic specificities.
    Fleischer AC; Cullinan JA; Kepple DM; Williams LL
    J Ultrasound Med; 1993 Dec; 12(12):705-12. PubMed ID: 8301708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of preoperative transvaginal sonography (TVS) in the description of tumor pattern in ovarian cancer patients: results of a prospective study.
    Henrich W; Fotopoulou C; Fuchs I; Wolf C; Schmider A; Denkert C; Lichtenegger W; Sehouli J
    Anticancer Res; 2007; 27(6C):4289-94. PubMed ID: 18214033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation.
    DePriest PD; Varner E; Powell J; Fried A; Puls L; Higgins R; Shenson D; Kryscio R; Hunter JE; Andrews SJ
    Gynecol Oncol; 1994 Nov; 55(2):174-8. PubMed ID: 7959280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal Risk Ovarian Screening Study: 21-Year Update.
    Han CY; Lu KH; Corrigan G; Perez A; Kohring SD; Celestino J; Bedi D; Bedia E; Bevers T; Boruta D; Carlson M; Holman L; Leeds L; Mathews C; McCann G; Moore RG; Schlumbrecht M; Slomovitz B; Tobias D; Williams-Brown Y; Bevers MW; Liu J; Gornet TG; Handy BC; Lu Z; Bedia JS; Skates SJ; Bast RC
    J Clin Oncol; 2024 Apr; 42(10):1102-1109. PubMed ID: 38194613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A morphology index based on sonographic findings in ovarian cancer.
    DePriest PD; Shenson D; Fried A; Hunter JE; Andrews SJ; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1993 Oct; 51(1):7-11. PubMed ID: 8244178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.